WallStreetZenWallStreetZen

NASDAQ: TNXP
Tonix Pharmaceuticals Holding Corp Stock Forecast, Predictions & Price Target

Analyst price target for TNXP

Based on 1 analyst offering 12 month price targets for Tonix Pharmaceuticals Holding Corp.
Min Forecast
$3.00+1,512.9%
Avg Forecast
$3.00+1,512.9%
Max Forecast
$3.00+1,512.9%

Should I buy or sell TNXP stock?

Based on 1 analyst offering ratings for Tonix Pharmaceuticals Holding Corp.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TNXP stock forecasts and price targets.

TNXP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-28

1 of 1

Forecast return on equity

Is TNXP forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.27%

Forecast return on assets

Is TNXP forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

TNXP revenue forecast

What is TNXP's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$18.1M+352.49%
Avg 2 year Forecast
$23.5M+488.27%
Avg 3 year Forecast
$199.0M+4,888.72%
TNXP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TNXP revenue growth forecast

How is TNXP forecast to perform vs Biotechnology companies and vs the US market?
Company
226.59%
Industry
39.22%
Market
10.52%
TNXP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TNXP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TNXP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TNXP$0.19$3.00+1,512.90%Strong Buy
GNPX$2.98$10.00+235.57%Buy
REVB$2.74N/AN/A
GOVX$2.00$120.00+5,900.00%Buy
JAGX$0.09N/AN/A

Tonix Pharmaceuticals Holding Stock Forecast FAQ

Is Tonix Pharmaceuticals Holding Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TNXP) stock is to Strong Buy TNXP stock.

Out of 1 analyst, 1 (100%) are recommending TNXP as a Strong Buy, 0 (0%) are recommending TNXP as a Buy, 0 (0%) are recommending TNXP as a Hold, 0 (0%) are recommending TNXP as a Sell, and 0 (0%) are recommending TNXP as a Strong Sell.

If you're new to stock investing, here's how to buy Tonix Pharmaceuticals Holding stock.

What is TNXP's revenue growth forecast for 2024-2026?

(NASDAQ: TNXP) Tonix Pharmaceuticals Holding's forecast annual revenue growth rate of 226.59% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Tonix Pharmaceuticals Holding's revenue in 2024 is $3,989,000.On average, 2 Wall Street analysts forecast TNXP's revenue for 2024 to be $430,480,605, with the lowest TNXP revenue forecast at $429,288,138, and the highest TNXP revenue forecast at $431,673,072. On average, 3 Wall Street analysts forecast TNXP's revenue for 2025 to be $559,648,636, with the lowest TNXP revenue forecast at $453,137,479, and the highest TNXP revenue forecast at $715,480,230.

In 2026, TNXP is forecast to generate $4,746,018,859 in revenue, with the lowest revenue forecast at $4,746,018,859 and the highest revenue forecast at $4,746,018,859.

What is TNXP's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: TNXP) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is TNXP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TNXP price target, the average TNXP price target is $3.00, with the highest TNXP stock price forecast at $3.00 and the lowest TNXP stock price forecast at $3.00.

The Wall Street analyst predicted that Tonix Pharmaceuticals Holding's share price could reach $3.00 by Feb 28, 2025. The average Tonix Pharmaceuticals Holding stock price prediction forecasts a potential upside of 1,512.9% from the current TNXP share price of $0.19.

What is TNXP's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: TNXP) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.